Data Integrity Educational Sessions at INTERPHEX
Experts will discuss regulatory requirements, best practices, and process security for data integrity at INTERPHEX 2018.
Pharmaceutical Technology will present the INTERPHEX Keynote Series: Data Integrity on Wednesday, April 18, 2018 on the show floor at the Innovation Stage, open to all show attendees.
Regulatory Requirements for Data Integrity, Applying ALCOA+: 11–11:30 am
Data integrity is crucial for both the pharmaceutical laboratory and the manufacturing floor. What is data integrity? How can a company ensure data integrity throughout their processes and facilities? Els Poff, Executive Director, Data Integrity Center of Excellence, Merck, representing the PDA Data Integrity Task Force, will answer these questions and more.
Click here to register for INTERPHEX.
Best Practices in Data Integrity and Process Security with Automated Systems: 11:30 am–12:30 pm
A panel of industry experts will discuss how to ensure data integrity with manufacturing automation systems, as well as cybersecurity, best practices for auditing system security, and security concerns associated with the Industrial Internet of Things. Panelists are: Bob Lenich, Global Life Sciences director, Emerson; Torsten Winkler, lead of the Life Sciences Center of Excellence in EMEA for Honeywell Process Solutions; Bob Mehta, Principal Consultant, MasterControl through GMP ISO Expert Services; Mark Cristiano, Manager, North America Business Development Team, Connected Services and Solutions, Rockwell Automation; and Nicolas Teissié, Siemens Industry Software Product Manager.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
3D Screen Printing: Enabling A New Generation of Complex Formulations
April 14th 20253D screen printing provides innovative drug development capabilities that are difficult or impossible to achieve with traditional methods, including complex multi-layered formulations, precision control over drug release profiles, and near-endless possibilities in the geometric shaping of dosage forms. In this article, learn how 3D screen printing offers unmatched flexibility to tailor formulations for specific therapeutic needs and redefines what’s possible in drug development and manufacturing.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
